expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)
TRT WorldVečer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidLazar BermanAgenciesLuke TressJessica SteinbergZev Stub
Tarik Cyril AmarMulatu Teshome WirtuThe Japan News EditorialJeremy SharonCharlie SummersReuters
Belen FernandezDavid HorovitzSam SokolAmanda Borschel-DanSharon WrobelSue SurkesBart SchutRobert NeffPhilissa Cramer
Maryam AldossariTania Krämer
Kersten KnippBen Sales
Patrick GatharaAida Touma-SlimanHassan Abo QamarMarko CrnkovičAmi Fields-Meyer
Rachel MarsdenBen KnightTommy WalkerVijaya Laxmi TripuraRossella TercatinJapan Today
Sabine KinkartzCathrin SchaerMurali Krishnan
Warren J. Blumenfeld
Gideon LevyDanica KirkaEric TuckerKristina Reymann-SchneiderJennifer HicksDiana BletterMatthew Ward Agius
Leonid Ragozin
|
 |
Bruce GilQuartz |
Elon Musk, the world’s richest person, lost billions of dollars in the first two months of the year, but he’s still holding onto his title.Read...
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this...
Big Pharma is pushing to bring back a tax break that could have saved them at least $15.4 billion in 2023 alone, according to a new analysis by...
President Donald Trump’s proposed tariffs on automakers could ripple beyond the automotive industry, with SiriusXM (SIRI) now expressing concern...
Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some short-term impacts from...
Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, and Eli Lilly...
Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight...
Pouya Shahbazian, a producer of the Divergent film franchise, has launched Staircase Studios AI, a film, television, and video game production company...
Over half of all adults — and a third of children and young adults — around the world are expected to be overweight or obese by 2050, according to...
Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, just got one step closer to its ambitious...
The House of Mouse had a stellar 2024. Its streaming business finally turned a profit, and its movie studios dominated the box office with the...
When Netflix (NFLX) debuted its video streaming service in 2007, its main selling point was that viewers could pick and watch what they wanted on...
Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the...
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about...
Pfizer (PFE) made some major changes to its diversity, equity, and inclusion (DEI) webpage on Thursday, joining other major American corporations that...
Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also made a wider range of...
Meta (META), the parent company of Facebook, has fired about 20 employees for leaking confidential information — and more terminations are...
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new...
Good morning, Quartz readers!Read more...
After hitting a record high this year, egg prices are set to rise even further.Read more...
After egg prices hit a record high last month, the Trump administration is finally rolling out its plan to “make eggs affordable again.”Read more...
Half of 2024’s top 10 highest-grossing films were animated movies — Inside Out 2 (DIS), Moana 2, Despicable Me 4 (CMCSA), Mufasa: The Lion King,...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against the U.S....
Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, the company will soon...
A twelfth person has died in connection to a multi-state listeria outbreak linked to frozen supplemental shakes served primarily in long-term care...
Hims & Hers (HIMS) stock took a steep dive, dropping more than 27%Tuesday morning — even after the millennial-focused telehealth company reported...
Eli Lilly (LLY) is making more doses of its blockbuster weight-loss drug Zepbound available in vials and at lower prices.Read more...
A three-judge panel in San Francisco denied the conviction appeal of Elizabeth Holmes on Monday, the founder of the blood-testing company...
Disney (DIS) and Warner Bros. Discovery (WBD) (WBD) teamed up last year with a new bundle that combines their streaming platforms under one monthly...
Target (TGT) was hit with another lawsuit on Thursday, this time by the state of Florida, which accused the retail giant of hiding the risks tied to...
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug...
UnitedHealth Group (UNH) is under fire over its Medicare billing practices.Read more...
Gilead (GILD) said on Tuesday that the U.S. Food and Drug Administration (FDA) has accepted its application for a twice-yearly injectable drug...
The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the world. Now, the pharma...
The e-commerce giant Amazon (AMZN) now owns and has creative control over the James Bond movie franchise.Read more...
In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid million of dollars to get ...
After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) is now expanding its...
Preventing HIV infections could soon be as simple as two shots a year.Read more...
In a bid to contain a bird flu outbreak that has sent egg prices soaring, the U.S. Department of Agriculture (USDA) last week granted a conditional...
Almost 20 years after Netflix (NFLX) debuted its video streaming platform in 2007, the company has been able to maintain — as one Wall Street...
Uber (UBER) CEO Dara Khosrowshahi would rather work with Tesla (TSLA) than be its rival.Read more...
Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s dominance over the weight-loss...
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight...
President Donald Trump on Thursday signed a memorandum that directs his advisers to draft new “fair and reciprocal” trade tariffs on all major...
Nestle CEO Laurent Freixe made the case for packaged foods just hours before Robert F. Kennedy Jr., a known critic of processed food, was confirmed as...
U.S. President Donald Trump’s tariffs are already having unintended and somewhat strange economic repercussions. For example, they have led to big...
Disney (DIS) is overhauling how it warns users on its streaming platform of older films that contain racial stereotypes. Read more...
Global life expectancy rebounded in 2022 after a two-year decline, though it has yet to recover to its 2019 peak, according to the latest data from...
Apple (AAPL) just launched a new major health study looking at how technology can help improve users’ physical and mental health, as well as overall...
A new study is adding to the growing body of evidence that Ozempic (NVO) and other GLP-1 medications could help people cut back on drinking...
login
who are we?
contact us
qosheapp
